135 related articles for article (PubMed ID: 9435899)
1. Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents.
Pierson ME; Comstock JM; Simmons RD; Kaiser F; Julien R; Zongrone J; Rosamond JD
J Med Chem; 1997 Dec; 40(26):4302-7. PubMed ID: 9435899
[TBL] [Abstract][Full Text] [Related]
2. CCK peptides with combined features of hexa- and tetrapeptide CCK-A agonists.
Pierson ME; Comstock JM; Simmons RD; Julien R; Kaiser F; Rosamond JD
J Med Chem; 2000 Jun; 43(12):2350-5. PubMed ID: 10882360
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
4. ARL 15849: a selective CCK-A agonist with anorectic activity in the rat and dog.
Simmons RD; Kaiser FC; Pierson ME; Rosamond JR
Pharmacol Biochem Behav; 1998 Feb; 59(2):439-44. PubMed ID: 9476993
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of novel, potent and long-acting analogs of AC-CCK-7 with high affinity for peripheral (type A) receptors.
Danho W; Makofske RC; Swistok J; Michalewsky J; Gabriel T; Marks N; Berg MJ; Baird L; Geiler V; Mackie G
Pept Res; 1991; 4(2):59-65. PubMed ID: 1815779
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
7. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger".
Aquino CJ; Armour DR; Berman JM; Birkemo LS; Carr RA; Croom DK; Dezube M; Dougherty RW; Ervin GN; Grizzle MK; Head JE; Hirst GC; James MK; Johnson MF; Miller LJ; Queen KL; Rimele TJ; Smith DN; Sugg EE
J Med Chem; 1996 Jan; 39(2):562-9. PubMed ID: 8558528
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.
Holladay MW; Bennett MJ; Tufano MD; Lin CW; Asin KE; Witte DG; Miller TR; Bianchi BR; Nikkel AL; Bednarz L
J Med Chem; 1992 Aug; 35(16):2919-28. PubMed ID: 1501220
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R
J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituent.
Hirst GC; Aquino C; Birkemo L; Croom DK; Dezube M; Dougherty RW; Ervin GN; Grizzle MK; Henke B; James MK; Johnson MF; Momtahen T; Queen KL; Sherrill RG; Szewczyk J; Willson TM; Sugg EE
J Med Chem; 1996 Dec; 39(26):5236-45. PubMed ID: 8978852
[TBL] [Abstract][Full Text] [Related]
12. Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2.
Goudreau N; Weng JH; Roques BP
Biopolymers; 1994 Feb; 34(2):155-69. PubMed ID: 8142585
[TBL] [Abstract][Full Text] [Related]
13. Effects of amylin on feeding of goldfish: interactions with CCK.
Thavanathan R; Volkoff H
Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity.
Balasubramaniam A; Mullins DE; Lin S; Zhai W; Tao Z; Dhawan VC; Guzzi M; Knittel JJ; Slack K; Herzog H; Parker EM
J Med Chem; 2006 Apr; 49(8):2661-5. PubMed ID: 16610810
[TBL] [Abstract][Full Text] [Related]
15. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors.
Shiosaki K; Lin CW; Kopecka H; Bianchi B; Miller T; Stashko M; Witte D
J Med Chem; 1997 Mar; 40(7):1169-72. PubMed ID: 9089338
[TBL] [Abstract][Full Text] [Related]
16. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
Escherich A; Lutz J; Escrieut C; Fourmy D; van Neuren AS; Müller G; Schafferhans A; Klebe G; Moroder L
Biopolymers; 2000-2001; 56(2):55-76. PubMed ID: 11592053
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in rat.
Ye Z; MacNeil T; Weinberg DH; Kalyani RN; Tang R; Strack AM; Murphy BA; Mosley RT; Euan MacIntyre D; Van der Ploeg LH; Patchett AA; Wyvratt MJ; Nargund RP
Peptides; 2005 Oct; 26(10):2017-25. PubMed ID: 15993513
[TBL] [Abstract][Full Text] [Related]
18. FPL 14294: a novel CCK-8 agonist with potent intranasal anorectic activity in the rat.
Simmons RD; Blosser JC; Rosamond JR
Pharmacol Biochem Behav; 1994 Mar; 47(3):701-8. PubMed ID: 8208791
[TBL] [Abstract][Full Text] [Related]
19. A71378: a CCK agonist with high potency and selectivity for CCK-A receptors.
Lin CW; Holladay MW; Witte DG; Miller TR; Wolfram CA; Bianchi BR; Bennett MJ; Nadzan AM
Am J Physiol; 1990 Apr; 258(4 Pt 1):G648-51. PubMed ID: 2333977
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
